photocreo-michal-bednarek-shutterstock-com

PHOTOCREO Michal Bednarek / Shutterstock.com

13 August 2015Peter Pitts

Why biopharma patents should be free from PTAB clutches

The UK’s pharmaceutical industry reportedly employs more than 70,000 workers and in 2013 contributed around £13 billion ($20.2 billion) to the economy.

Already registered?

Login to your account

For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Adrian Tapping at atapping@newtonmedia.co.uk

More features

China’s new policies on foreign investment in healthcare and biotech

Startup CFO’s betrayal is a lesson in preparing for the worst

How post-filing data rescued Novo Nordisk’s Ozempic patent in China

How to navigate patent term adjustment in China

Preventative IP for preventative pharma healthcare

Dexcom suffers second patent revocation at hands of UPC

Does the UPC offer a fresh take on patent validity?

Litigation implications of the USPTO’s terminal disclaimer proposal